Key takeaways: Healthcare organizations are facing growing levels of bad debt and a sharp decline in...
Health
Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment
Ovarian cancer remains one of the most difficult-to-treat diseases. With all our advances in screening and...
Q&A: How AI innovation is transforming healthcare revenue cycle management
Healthcare organizations are facing a perfect storm: rising claim denials, evolving payer rules, and patients...
The Sunrise Group Raises $29M to Expand Digital Sleep Clinic
The Sunrise Group, a sleep health company, has secured $29 million in funding, which it will use to fuel the...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent...
If Not Now, When? – The Health Care Blog
By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy...
Lessons From The Medical Error That Orphaned A Cabinet Secretary – The Health Care Blog
By MICHAEL MILLENSON It was a small anecdote, buried in a lengthy profile in The New Yorker of Commerce...
WTW: Half of Employers Exceeded Their Healthcare Budgets in 2024
It’s no secret that employers are struggling when it comes to healthcare costs. A new survey from Willis Towers...
And Yet It Moves – The Health Care Blog
By KIM BELLARD Science buffs will recognize the title as the (possibly apocryphal) quote Galileo muttered after...
State of Claims 2025: The denial problem (and is AI the answer?)
Key takeaways: Experian Health’s State of Claims 2025 report is out now, detailing providers’ views on claims...
New Bereavement Cost Calculator shows that grief is expensive – The Health Care Blog
by EMMA PAYNE Grief is expensive. In addition to the significant human impacts, research shows that bereavement...
Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major Player in Obesity Drugs & More
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field...
Subscribe
Recommended
